Advanced Renal Cell Carcinoma (aRCC)
4 clinical trials · Condition
◉ Watch Advanced Renal Cell Carcinoma (aRCC)
| Record | Firm | Date |
|---|---|---|
| Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing Combination (NCT04957160) | Ipsen | 2021-09-09 |
Track Advanced Renal Cell Carcinoma (aRCC) automatically
Every clearance here is in the API, with alerts when new ones post.